ASND· Ascendis Pharma A/S
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 6 quarters
ASND Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$14.7B
Enterprise value$15.0B
EV / EBITDA (TTM)-5540.92
P/E ratio (TTM)26.82
Forward P/E20.65
P/S ratio17.03
P/B ratio25.59
PEG ratio—
Cash Flow
Operating cash flow (TTM)$60M
Free cash flow (TTM)$124M
Total cash$573M
Total debt$897M
Debt / equity183.75
Current ratio1.00
Income Statement
Total revenue (TTM)$866M
Revenue per share (TTM)14.18
Gross profit (TTM)$771M
EBITDA (TTM)-$3M
Net income (TTM)$496M
EPS diluted (TTM)8.90
Shares outstanding61,779,750
Float shares61,699,901
Profitability
Gross margin89.04%
Operating margin10.06%
EBITDA margin-0.31%
Net margin57.28%
Efficiency
Return on assets (TTM)-0.30%
Return on equity (TTM)332.65%
Price History
Current price$238.66
52 Week high$250.74
52 Week low$150.89
50 day average$231.60
200 day average$211.87
Average volume (10 day)941,260
1-year beta—
1-year price target$297.04
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:35 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com